▶ Changes in urinary albumin excretion ▶ Decline in glomerular filtration rate (GFR) ▶ Development or intensification of hypertension, dyslipoproteinaemia or other complications typical in diabetes patients. The nephropathy stages and associated secondary diseases are given in • " Table 1 .
Screening and Diagnosis

!
Screening once a year by determining the albumin concentration in the patient's urine ( • " Fig. 1 ). Annual determination of estimated GFR (eGFR) is recommended because the kidney function of diabetic patients can be limited even without albuminuria (e. g. with ischemic nephropathy). Exception: patients with greatly restricted life expectancy and presence of factors which can lead to transient elevation of urinary albumin excretion, e. g. as with physical exertion, illnesses with acute fever, infection of the urinary tract, improperly controlled diabetes, poorly controlled hypertension, heart failure. The diagnosis "diabetic nephropathy" can be assumed to be highly probably if there is a persistent albuminuria, i. e. the albumin / creatinine ratio in the patient's urine exceeds 20 mg/g for men or 30 mg/g for women when measured in two samples separated by a period of 2 to 4 weeks ( • " Fig. 2 ).
Differential Diagnosis
!
Indications of a kidney disease that is not diabetic are: a) With presence of elevated urinary albumin excretion:
▶ Pathologic urine sediment (particularly dysmorphic erythrocytes, erythrocyte cylinders or leukocytes), ▶ Rapid increase of proteinuria, ▶ Extremely high proteinuria (> 6 g / 24 h) ▶ Rapid rise in creatinine ▶ Atypical sonographic changes of the kidneys, i. e. especially contracted kidneys or asymmetric kidney size.
▶ Type 1 diabetes diagnosed less than 5 years ago.
Nephrology referral for further work-up is strongly recommended! b) With absence of elevated urinary albumin excretion: Renal insufficiency without micro or macro albuminuria is usually ischemic (hypertensive nephropathy). The therapy is largely that for treating diabetic nephropathy. Further imaging studies (duplexsonograph, MRI) are recommended in cases of suspicion of renal arterial stenosis, e. g. with asymmetric kidney sizes, abdominal vascular murmurs, hypertension that is difficult to control (more than four antihypertensives), rise of serum creatinine to more than 50 % of the initial value caused by ACE inhibitor or AT 1 receptor receptor block therapy, or small kidney on just one side (sonograph).
Further Diagnostic Work-Up ▶ Anaemia (Hb < 13 g/dl for men, Hb < 12 g/dl for women: renal aetiology can be assumed if other causes such as disturbance of iron balance, chronic inflammations, gastrointestinal bleeding, etc., have been excluded. Anaemia occurs earlier in connection with diabetic nephropathy than with other kidney diseases.
Therapy Objectives and Therapy
!
The development and progression of diabetic nephropathy can be accelerated by:
By influencing these factors, one can prevent or at least slow down the development and/or progression of diabetic nephropathy. Since patients with diabetic nephropathy have an excessive cardiovascular risk, consistent treatment of the other cardiovascular risk factors, in particular increases in LDL cholesterol and increased platelet aggregation, are likewise required. This also applies to diabetic patients with nephropathy that is primarily due to ischemic conditions (i. e. without albuminuria).
Diabetes Control
! ▶ In primary prevention of nephropathy, one should aim for an HbA1c level between 6.5 % (48 mmol/mol) and 7.5 % (58 mmol/ mol). The upper half of this range (7.0 -7.5 % [53 -58 mmol/ mol]) applies to patients with macroangiopathic complications or impaired hypoglycaemia awareness.
▶ In secondary prevention, one should aim for an HbA1c level under 7.0 % (< 53 mmol/mol) if clinically relevant macroangiopathy or hypoglycaemia awareness impairment can be excluded.
▶ As a rule, the HbA1c level underestimates the quality of metabolism control in cases of kidney insufficiency (GFR at 60 ml/min or lower), in particular with parallel erythropoietin or iron therapy.
Important
!
The following points are of special importance when renal function is declining:
▶ Metformin: contraindicated if eGFR < 60 ml/min ▶ Glucosidase inhibitors: no recommendation can be issued, due to a lack of studies ▶ Sulfonylureas: as a rule, reduce the dose (exception: gliquidone); contraindication if eGFR < 30 ml/min. 
Blood Pressure Control
!
Normotensive type 1 and type 2 diabetics with persistently elevated urinary albumin excretion should be treated with an ACE inhibitor if this can be tolerated, otherwise with an AT 1 blocker. The systolic blood pressure of hypertensive patients with nephropathy should be reduced strictly < 140/90 mmHg. Target blood pressures should be selected individually depending on:
▶ Urinary albumin excretion (target blood pressure should be decreased when proteinuria increases).
▶ Cardiovascular comorbodity
Pharmacologic therapy should rely primarily on the following medications:
Type 1 Diabetes
ACE inhibitors
1 − unless they cannot be tolerated, in which case AT1 blockers − alone or in combination with diuretics and/or other substances.
Type 2 Diabetes
AT 1 blockers or ACE inhibitors 1 alone or in combination with diuretics and/or other substances. Fig. 3 ).
Further Therapeutic Measures
Beginning with stage 3, i. e. when creatinine clearance < 60 ml/ min, check the following in addition:
▶ Haemoglobin, haematocrit, ▶ Serum phosphate, serum calcium, ▶ Parathyroid hormone, Vitamin D, as applicable.
Refer to nephrologist for special management issues or if eGFR falls < 30 ml/min. Fig. 1 Examination for diabetic nephropathy. 1 When using test strips, one must take the detection sensitivity of the albumin concentration into account. The following are suitable for albumin concentrations < 200 mg/l: Micraltest II, Microalbu-Stix. 2 Albumin concentration can be temporarily elevated, e. g. with physical exertion, acute illness with fever, infection of the urinary tract, poorly controlled diabetes, poorly controlled hypertension, heart failure. 3 A laboratory chemical method should be used for the second check. This allows graduation of albuminuria for higher concentrations: Microalbuminuria: m: 20 -200 mg/g urinary creatinine w: 30 -300 mg/g urinary creatinine Macroalbuminuria: m: > 200 mg/g urinary creatinine w: > 300 mg/g urinary creatinine Fig. 2 Diagnosis of diabetic nephropathyalgorithm. Fig. 3 Calculation of creatinine clearance.
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